Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Mad Money
Eli Lilly and Co
Eisai Co Ltd
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Stock markets
stocks
Kratos Defense and Security Solutions Inc
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Eisai Co Ltd
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Alphabet Inc
Politics
Investment strategy
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Business
Pharmaceuticals
Biotechnology
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Biogen Inc
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Health care industry
Eisai Co Ltd
Earnings
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
5 Things to Know
Airbnb Inc
Business News
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Eisai Co Ltd
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
MGM Resorts International
5 Things to Know
Walt Disney Co
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Biotech and Pharmaceuticals
Depression
Health care industry
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
First Solar Inc
New York Community Bancorp Inc
Pfizer Inc
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Finance
Progressive Corp
Sherwin/Williams Co
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Pharmaceuticals
Business
Wells Fargo & Co
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Investing
Tesla Inc
Biogen Inc
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Alzheimer's disease
Breaking news
Business
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Policy
Eisai Co Ltd
Health care industry
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
Eisai Co Ltd
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
Alibaba Group Holding Ltd
Eisai Co Ltd
First Solar Inc
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Market Insider
Finance
Markets
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
World Markets
Pharmaceuticals
Asia Markets
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Business
World News
Science
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Morgan Stanley
Norwegian Cruise Line Holdings Ltd
Royal Caribbean Cruises Ltd
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Policy
Health care industry
Eisai Co Ltd
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
US Economy
US: News
Biogen Inc
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Markets
Investment strategy
Stock Picks
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Alzheimer's disease
Business
Biotechnology
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Eli Lilly and Co
Finance
Markets
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.